Araceli Tobio

Santiago De Compostela, GA, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer.

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer.

Journal: Molecular oncology

Published: November 03, 2024

Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines.

Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines.

Journal: Drug delivery and translational research

Published: May 21, 2024

Critical Signaling Events in the Mechanoactivation of Human Mast Cells through p.C492Y-ADGRE2.

Critical Signaling Events in the Mechanoactivation of Human Mast Cells through p.C492Y-ADGRE2.

Journal: The Journal of investigative dermatology

Published: November 15, 2019

Oncogenic D816V-KIT signaling in mast cells causes persistent IL-6 production.

Oncogenic D816V-KIT signaling in mast cells causes persistent IL-6 production.

Journal: Haematologica

Published: November 16, 2018

Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT.

Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT.

Journal: Frontiers in immunology

Published: November 21, 2017

Yessotoxin, a Marine Toxin, Exhibits Anti-Allergic and Anti-Tumoural Activities Inhibiting Melanoma Tumour Growth in a Preclinical Model.

Yessotoxin, a Marine Toxin, Exhibits Anti-Allergic and Anti-Tumoural Activities Inhibiting Melanoma Tumour Growth in a Preclinical Model.

Journal: PloS one

Published: June 01, 2016

Identification of Biological and Pharmaceutical Mast Cell- and Basophil-Related Targets.

Identification of Biological and Pharmaceutical Mast Cell- and Basophil-Related Targets.

Journal: Scandinavian journal of immunology

Published: February 10, 2016

C-kit mutations determine dasatinib mechanism of action in HMC-1 neoplastic mast cells: dasatinib differently regulates PKCδ translocation in HMC-1(560) and HMC-1(560,816) cell lines.

C-kit mutations determine dasatinib mechanism of action in HMC-1 neoplastic mast cells: dasatinib differently regulates PKCδ translocation in HMC-1(560) and HMC-1(560,816) cell lines.

Journal: Immunopharmacology and immunotoxicology

Published: July 17, 2015

Cross-talks between c-Kit and PKC isoforms in HMC-1(560) and HMC-1(560,816) cells. Different role of PKCδ in each cellular line.

Cross-talks between c-Kit and PKC isoforms in HMC-1(560) and HMC-1(560,816) cells. Different role of PKCδ in each cellular line.

Journal: Cellular immunology

Published: September 14, 2014

PKC potentiates tyrosine kinase inhibitors STI571 and dasatinib cytotoxic effect.

PKC potentiates tyrosine kinase inhibitors STI571 and dasatinib cytotoxic effect.

Journal: Anticancer research

Published: July 02, 2014

Role of AKAP 149-PKA-PDE4A complex in cell survival and cell differentiation processes.

Role of AKAP 149-PKA-PDE4A complex in cell survival and cell differentiation processes.

Journal: The international journal of biochemistry & cell biology

Published: January 27, 2014

Different role of cAMP pathway on the human mast cells HMC-1(560) and HMC-1(560,816) activation.

Different role of cAMP pathway on the human mast cells HMC-1(560) and HMC-1(560,816) activation.

Journal: Journal of cellular biochemistry

Published: November 27, 2013

Showing 1-12 of 16

Last Updated: 09/26/2026